Our pharmaceutical portfolio spans multiple therapeutic areas, each product engineered to meet the highest standards of purity, potency, and stability. Explore our range and enquire directly.
A third-generation cephalosporin–sulbactam combination delivering broad-spectrum bactericidal activity against resistant gram-negative and gram-positive organisms, including beta-lactamase-producing strains.
An extended-spectrum penicillin combined with tazobactam for treatment of serious hospital-acquired infections including nosocomial pneumonia, intra-abdominal sepsis, and complicated urinary tract infections. Supplied with WFI.
A broad-spectrum carbapenem antibiotic with potent activity against multidrug-resistant gram-negative and gram-positive pathogens. Indicated for empiric treatment of severe nosocomial infections and febrile neutropenia.
An aminopenicillin combined with potassium clavulanate extending antibiotic coverage to include beta-lactamase-producing organisms. Effective for respiratory, urinary, skin, and soft tissue infections in hospital settings.
A combination of the third-generation cephalosporin ceftriaxone with the beta-lactamase inhibitor sulbactam, providing enhanced bactericidal activity against resistant organisms in respiratory, urinary, and surgical site infections.
A ready-to-use pre-filled syringe containing enoxaparin sodium for subcutaneous administration. Indicated for VTE prophylaxis in moderate-to-high risk surgical and medical patients with consistent anti-Xa activity.
A therapeutic-dose low molecular weight heparin in a pre-filled syringe for treatment of deep vein thrombosis, pulmonary embolism, and management of acute coronary syndromes including NSTEMI and unstable angina.
Unfractionated heparin at a standard prophylactic concentration for subcutaneous or intravenous use. Indicated for prevention of venous thromboembolism in surgical and high-risk medical patients with rapid reversibility via protamine sulfate.
High-concentration unfractionated heparin for continuous intravenous infusion in treatment of acute thromboembolic events including pulmonary embolism and deep vein thrombosis. Requires aPTT monitoring for therapeutic dosing.
A lyophilized pantoprazole injection providing rapid, potent acid suppression through irreversible blockade of the gastric H+/K+ ATPase pump. Indicated for GERD, peptic ulcer disease, and Zollinger-Ellison syndrome when oral therapy is not feasible.
Hydrocortisone sodium succinate for intravenous or intramuscular administration in acute adrenal insufficiency, anaphylaxis, status asthmaticus, and severe inflammatory conditions. Rapid onset with full glucocorticoid and mineralocorticoid activity.
Tranexamic acid injection for prevention and treatment of hemorrhage by competitively inhibiting plasminogen activation. Indicated for perioperative blood loss, postpartum hemorrhage, and traumatic bleeding — backed by Level 1 clinical evidence.
Try a different search term or .
We work with hospitals, pharmacy chains, and healthcare institutions on custom supply agreements, branded formulations, and bulk orders. Our team will evaluate your requirements and come back with a tailored proposal.